Tag: #Global Trends

Following a year-long strategic review, Viatris announced on February 26, 2026, a plan to reduce its global workforce by approximately... Read more

At the 33rd Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented 96-week data from the Mocha study (IMPAACT... Read more

On February 26, 2026, the FDA granted expanded approval for Boehringer Ingelheim’s Hernexeos (zongertinib) as a first-line treatment for patients... Read more

On February 25, 2026, the U.S. Food and Drug Administration (FDA) issued full approval for Pfizer’s Braftovi (encorafenib) in combination... Read more

Novartis has unveiled plans to construct a new radioligand therapy (RLT) manufacturing facility in Denton, Texas. This project marks a... Read more

Gilead Sciences has released detailed results from two pivotal clinical trials, Artistry-1 and Artistry-2, evaluating a novel investigational combination tablet... Read more

Bioprocessing leaders NorthX Biologics and Demeetra have launched a strategic collaboration designed to help biotech companies rapidly reach Investigational New... Read more

Pharmaceutical giant AbbVie has unveiled plans to invest $380 million in the construction of two new active pharmaceutical ingredient (API)... Read more

Merck & Co. has announced a major reorganization of its "Human Health" organization to better prepare for the upcoming loss... Read more